Journal
JOURNAL OF NANOBIOTECHNOLOGY
Volume 20, Issue 1, Pages -Publisher
BMC
DOI: 10.1186/s12951-022-01324-w
Keywords
Interstitial radiotherapy; Biomimetic radiosensitizers; Radiogenetics; PD-L1 upregulation; Hypoxic and immunosuppressive microenvironment
Funding
- National Natural Science Foundation of China [82071956, 82022033]
- Clinical Research Plan of SHDC [2020CR4065]
- National Key Research and Development Program of China [2016YFC0104303]
- Shanghai Rising-Star Program [19QA1406800]
- Shanghai Talent Development Fund [2019040]
Ask authors/readers for more resources
By designing Mn-based IRT radiosensitizers, local interstitial radiotherapy can be enhanced to address the insufficient systematic immune responses and inhibit tumor metastasis by remodeling the tumor microenvironment and activating immune responses.
Background: Similar to other local therapeutic methods, local interstitial radiotherapy (IRT) also suffers from insufficient systematic immune activation, resulting in tumor metastasis. Results: Mn-based IRT radiosensitizers consisting of I-131, MnO2 and bovine serum albumin (BSA) (I-131-MnO2-BSA) were engineered. Such Mn-based IRT radiosensitizers successfully unlocked radiogenetics to magnify systematic immune responses of local IRT via remodeling hypoxic and immunosuppressive microenvironments and resist tumor metastasis. The MnO2 in I-131-MnO2-BSA caused decomposition of H2O2 enriched in tumors to generate O-2 for alleviating hypoxic microenvironment and removing tumor resistances to IRT. Concurrently, hypoxia mitigation by such radiosensitizers-unlocked radiogenetics can effectively remodel immunosuppressive microenvironment associated with regulatory T (Treg) cells and tumor-associated macrophages (TAMs) infiltration inhibition to induce immunogenic cell death (ICD), which, along with hypoxia mitigation, activates systematic immune responses. More intriguingly, I-131-MnO2-BSA-enabled radiogenetics can upregulate PD-L1 expression, which allows anti-PD-L1-combined therapy to exert a robust antitumor effect on primary tumors and elicit memory effects to suppress metastatic tumors in both tumor models (4T1 and CT26). Conclusions: IRT radiosensitizer-unlocked radiogenetics and the corresponding design principle provide a general pathway to address the insufficient systematic immune responses of local IRT.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available